|
Our drug safety group is comprised of seasoned M.D., Ph.D., and Pharm.D.-level epidemiologists and pharmacovigilance specialists. We have appeared to explain, present, and defend our work before the FDA, EMEA, and scores of professional congresses. Leading experts in the drug safety industry, our published, respected researchers provide answers to drug safety issues to help you lessen drug safety risks. If you have a difficult decision to make, rely on i3 Drug Safety for insight and experience.
Biographies
|
Terri Madison, PhD, MPH
President, i3 Drug Safety |
|
|
|
|
Kin Wei (Arnold) Chan, M.D., Sc.D. |
Wendy J. Carman |
|
|
|
Paul Dolin, MPH, DPhil |
Donnie P. Funch, Ph.D., M.S. |
|
|
|
Karen Goss, RN, BSN, MBA |
Jeanne E. Loughlin, M.S. |
|
|
|
Andrew T. McAfee, M.D., M.S. |
John D. Seeger, PharmD, DrPH |
|
|
|
Mary Varterasian, MD
|
|
|
|
|
| |
